Open-label, Single-arm Study to Assess the Pharmacokinetics, Safety, and Tolerability of a Single Subcutaneous Dose of Icatibant in Healthy Japanese Volunteers

Conditions

• Hereditary Angioedema (HAE)

Interventions

• DRUG: Icatibant (30 mg)

Sponsor

Shire